Short Interest in Nuwellis, Inc. (NASDAQ:NUWE) Decreases By 14.3%

Nuwellis, Inc. (NASDAQ:NUWE) was the target of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 178,100 shares, a decrease of 14.3% from the February 28th total of 207,800 shares. Currently, 4.1% of the shares of the stock are sold short. Based on an average daily volume of 481,900 shares, the short-interest ratio is currently 0.4 days.

Institutional Investors Weigh In On Nuwellis

A hedge fund recently bought a new stake in Nuwellis stock. Geode Capital Management LLC bought a new stake in shares of Nuwellis, Inc. (NASDAQ:NUWE) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 30,806 shares of the company’s stock, valued at approximately $34,000. Geode Capital Management LLC owned about 0.70% of Nuwellis as of its most recent SEC filing. Institutional investors own 3.13% of the company’s stock.

Nuwellis Stock Up 2.8 %

NASDAQ:NUWE traded up $0.03 during trading hours on Wednesday, reaching $0.99. 4,747 shares of the company’s stock were exchanged, compared to its average volume of 995,554. The company has a market capitalization of $4.31 million, a P/E ratio of -0.01 and a beta of 0.36. Nuwellis has a 12 month low of $0.90 and a 12 month high of $14.35. The business’s 50-day simple moving average is $1.20 and its two-hundred day simple moving average is $1.32.

About Nuwellis

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.